Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by EHAB Y HANNA and DIANA BELL.
EHAB Y HANNA
Connection Strength
11.596
DIANA BELL
  1. Intestinal-Type Adenocarcinoma in Head and Neck: Dissecting Oncogenic Gene Alterations Through Whole Transcriptome and Exome Analysis. Mod Pathol. 2024 Jan; 37(1):100372.
    View in: PubMed
    Score: 0.968
  2. Olfactory Neuroblastoma: Morphological Reappraisal and Molecular Insights with Quantum Leap in Clinical Perspectives. Curr Oncol Rep. 2023 01; 25(1):11-18.
    View in: PubMed
    Score: 0.908
  3. High-grade transformation of low-grade biphenotypic sinonasal sarcoma: Radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol. 2022 Apr; 57:151889.
    View in: PubMed
    Score: 0.854
  4. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome. Ann Diagn Pathol. 2020 Dec; 49:151622.
    View in: PubMed
    Score: 0.778
  5. Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck. 2019 09; 41(9):3090-3104.
    View in: PubMed
    Score: 0.708
  6. Cellular subtype may predict survival outcomes in salivary adenoid cystic carcinoma patients-a single-institution experience. Virchows Arch. 2018 Mar; 472(3):505-512.
    View in: PubMed
    Score: 0.638
  7. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes. Head Neck Pathol. 2015 Mar; 9(1):51-9.
    View in: PubMed
    Score: 0.502
  8. Head and neck adenoid cystic carcinoma: what is new in biological markers and treatment? Curr Opin Otolaryngol Head Neck Surg. 2013 Apr; 21(2):124-9.
    View in: PubMed
    Score: 0.465
  9. Sinonasal undifferentiated carcinoma: morphological heterogeneity, diagnosis, management and biological markers. Expert Rev Anticancer Ther. 2013 Mar; 13(3):285-96.
    View in: PubMed
    Score: 0.462
  10. Salivary gland cancers: biology and molecular targets for therapy. Curr Oncol Rep. 2012 Apr; 14(2):166-74.
    View in: PubMed
    Score: 0.434
  11. Optimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and Lung. Curr Oncol Rep. 2023 01; 25(1):1-10.
    View in: PubMed
    Score: 0.227
  12. International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System. J Neurol Surg B Skull Base. 2023 Aug; 84(4):307-319.
    View in: PubMed
    Score: 0.221
  13. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Laryngoscope. 2022 02; 132(2):290-297.
    View in: PubMed
    Score: 0.207
  14. The tumor immune contexture of salivary duct carcinoma. Head Neck. 2021 04; 43(4):1213-1219.
    View in: PubMed
    Score: 0.200
  15. Neuroendocrine Carcinoma and Sinonasal Undifferentiated Carcinoma. Adv Otorhinolaryngol. 2020; 84:168-184.
    View in: PubMed
    Score: 0.193
  16. Uncommon tumors of temporomandibular joint: An institutional experience and review. Head Neck. 2020 08; 42(8):1859-1873.
    View in: PubMed
    Score: 0.187
  17. Identification of markers predictive for response to induction chemotherapy in patients with sinonasal undifferentiated carcinoma. Oral Oncol. 2019 10; 97:56-61.
    View in: PubMed
    Score: 0.181
  18. Identification of novel diagnostic markers for sinonasal undifferentiated carcinoma. Head Neck. 2019 08; 41(8):2688-2695.
    View in: PubMed
    Score: 0.176
  19. Sinonasal Undifferentiated Carcinoma. Curr Oncol Rep. 2019 02 26; 21(3):26.
    View in: PubMed
    Score: 0.175
  20. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J Clin Oncol. 2019 02 20; 37(6):504-512.
    View in: PubMed
    Score: 0.173
  21. Massive aneurysmal bone cyst of the skull base treated with denosumab. Head Neck. 2018 12; 40(12):E107-E113.
    View in: PubMed
    Score: 0.172
  22. Outcomes for olfactory neuroblastoma treated with induction chemotherapy. Head Neck. 2017 08; 39(8):1671-1679.
    View in: PubMed
    Score: 0.155
  23. Addendum to Bell et al's "In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type". Cancer. 2016 07 15; 122(14):2278-9.
    View in: PubMed
    Score: 0.144
  24. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type. Cancer. 2016 May 15; 122(10):1513-22.
    View in: PubMed
    Score: 0.142
  25. Reappraisal of sinonasal undifferentiated carcinoma: SMARCB1 (INI1)-deficient sinonasal carcinoma: a single-institution experience. Virchows Arch. 2015 Dec; 467(6):649-656.
    View in: PubMed
    Score: 0.138
  26. Neuroendocrine neoplasms of the sinonasal region. Head Neck. 2016 04; 38 Suppl 1:E2259-66.
    View in: PubMed
    Score: 0.136
  27. Analysis and significance of c-MET expression in adenoid cystic carcinoma of the salivary gland. Cancer Biol Ther. 2015; 16(6):834-8.
    View in: PubMed
    Score: 0.134
  28. Achaete-scute homolog 1 expression closely correlates with endocrine phenotype and degree of differentiation in sinonasal neuroendocrine tumors. Ann Diagn Pathol. 2015 Jun; 19(3):154-6.
    View in: PubMed
    Score: 0.134
  29. Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system. Curr Oncol Rep. 2015 Jan; 17(1):423.
    View in: PubMed
    Score: 0.131
  30. Esthesioneuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma: differentiation in diagnosis and treatment. Int Arch Otorhinolaryngol. 2014 Oct; 18(Suppl 2):S149-56.
    View in: PubMed
    Score: 0.129
  31. Comprehensive assessment of prognostic markers for sinonasal squamous cell carcinoma. Head Neck. 2014 Aug; 36(8):1094-102.
    View in: PubMed
    Score: 0.121
  32. Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma. Ann Diagn Pathol. 2014 Feb; 18(1):10-3.
    View in: PubMed
    Score: 0.121
  33. Esthesioneuroblastoma. Neurosurg Clin N Am. 2013 Jan; 24(1):51-65.
    View in: PubMed
    Score: 0.114
  34. Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma. Clin Cancer Res. 2012 Nov 15; 18(22):6178-87.
    View in: PubMed
    Score: 0.112
  35. ALDH1 immunohistochemical expression and its significance in salivary adenoid cystic carcinoma. Head Neck. 2013 Apr; 35(4):575-8.
    View in: PubMed
    Score: 0.109
  36. Clinical significance of Myb protein and downstream target genes in salivary adenoid cystic carcinoma. Cancer Biol Ther. 2011 Oct 01; 12(7):569-73.
    View in: PubMed
    Score: 0.105
  37. Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach. Transl Oncol. 2024 Apr 08; 44:101943.
    View in: PubMed
    Score: 0.062
  38. International Consensus Statement on Allergy and Rhinology: Sinonasal Tumors. Int Forum Allergy Rhinol. 2024 Feb; 14(2):149-608.
    View in: PubMed
    Score: 0.061
  39. Phase II Clinical Trial of Axitinib and Avelumab in Patients With Recurrent/Metastatic Adenoid Cystic Carcinoma. J Clin Oncol. 2023 05 20; 41(15):2843-2851.
    View in: PubMed
    Score: 0.058
  40. Human papillomavirus status and prognosis of oropharyngeal high-grade neuroendocrine carcinoma. Oral Oncol. 2023 03; 138:106311.
    View in: PubMed
    Score: 0.057
  41. Soft Tissue Sarcomas of the Head and Neck Region with Skull Base/Intracranial Invasion: Review of Surgical Outcomes and Multimodal Treatment Strategies: A Retrospective Case Series. Curr Oncol. 2022 09 14; 29(9):6540-6550.
    View in: PubMed
    Score: 0.056
  42. Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma. Eur J Cancer. 2022 02; 162:221-236.
    View in: PubMed
    Score: 0.053
  43. Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified. Cancer. 2022 02 01; 128(3):509-518.
    View in: PubMed
    Score: 0.053
  44. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies. Laryngoscope. 2021 05; 131(5):E1468-E1475.
    View in: PubMed
    Score: 0.049
  45. Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2020 Jun 12; 134(5):1392-1398.
    View in: PubMed
    Score: 0.048
  46. Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma. Oral Oncol. 2020 02; 101:104523.
    View in: PubMed
    Score: 0.046
  47. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck. 2018 12; 40(12):2596-2605.
    View in: PubMed
    Score: 0.043
  48. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope. 2018 06; 128(6):1274-1280.
    View in: PubMed
    Score: 0.040
  49. Desmoplastic Small Round Cell Tumor Presenting as an Ocular Mass: Unusual Localization and Remarkable Surgical Approach. Curr Oncol Rep. 2017 Oct 18; 19(12):80.
    View in: PubMed
    Score: 0.040
  50. Eye-sparing multidisciplinary approach for the management of lacrimal gland carcinoma. Head Neck. 2016 08; 38(8):1258-62.
    View in: PubMed
    Score: 0.036
  51. Human epidermal growth factor receptor 2/neu as a novel therapeutic target in sinonasal undifferentiated carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1926-34.
    View in: PubMed
    Score: 0.035
  52. Prognostic factors in adenocarcinoma of the salivary glands. Oral Oncol. 2015 Jun; 51(6):610-5.
    View in: PubMed
    Score: 0.033
  53. Human papillomavirus and WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010 Oct; 120(10):1990-7.
    View in: PubMed
    Score: 0.024
  54. Human papillomavirus & WHO type I nasopharyngeal carcinoma. Laryngoscope. 2010; 120 Suppl 4:S185.
    View in: PubMed
    Score: 0.023
  55. Molecular and phenotypic analysis of poorly differentiated sinonasal neoplasms: an integrated approach for early diagnosis and classification. Hum Pathol. 2009 Mar; 40(3):283-92.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.